Intervention Program to Address PTSD in People Living With HIV

Sponsor
Central South University (Other)
Overall Status
Completed
CT.gov ID
NCT05588596
Collaborator
(none)
82
1
2
10.9
7.5

Study Details

Study Description

Brief Summary

The goal of this randomised controlled trial is to evaluate the efficacy of an integrated intervention program on post-traumatic stress disorder (PTSD) symptoms and related physiological and psychological indicators of people living with HIV (PLWH). The main question it aims to answer are:

  • to evaluate the efficacy of the intervention program on PTSD symptoms and related physiological and psychological indicators of PLWH through empirical research.

  • to analyze the mechanism of the intervention. Eligible PLWH were recruited and randomly divided as intervention group and control group. The efficacy of Trauma Resiliency Mindfulness-Informed Intervention on PTSD symptoms and related physiological and psychological indicators in PLWH was evaluated at baseline, after intervention, and 3 months after intervention through this randomized controlled trial.

Researchers compared the intervention group and control group to see if it was feasible and had potential clinical value to introduce the Trauma Resiliency Mindfulness-Informed intervention program into the management of PLWH in China.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Trauma Resiliency Mindfulness-Informed Intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
82 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Developing and Validating an Integrative Model Incorporating Mindfulness-based Resilience Intervention to Address Post-Traumatic Stress Disorder in People Living With HIV
Actual Study Start Date :
May 3, 2020
Actual Primary Completion Date :
Jan 30, 2021
Actual Study Completion Date :
Mar 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

Access to routine hospital care and outpatient services. Patients received relevant health counseling provided by the investigator. In addition, Patients received Trauma Resiliency Mindfulness-Informed Intervention, including Mindfulness awareness, body scanning, walking awareness, mindful breathing, etc.

Behavioral: Trauma Resiliency Mindfulness-Informed Intervention
The total duration of the intervention was once a week for eight weeks. The aim of the intervention was to teach patients a range of trauma recovery mindfulness skills

No Intervention: Waitlist group

Access to routine hospital care and outpatient services. In addition, the patient received relevant health counseling provided by the investigator, including AIDS related knowledge counseling, diet advice, etc. At the end of the study, patients in the waitlist group were provided with intervention.

Outcome Measures

Primary Outcome Measures

  1. Change of PTSD symptoms [Outcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the intervention]

    PTSD CheckList - Civilian Version (PCL-C) was used. The scale consists of 17 items divided into 3 dimensions. Each dimension is scored from 1 to 5. The total score of PCL-C ranges from 17 to 85, with higher scores indicating severer PTSD symptoms.

Secondary Outcome Measures

  1. Change of depression symptoms [Outcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the intervention]

    The Zung Self-Rating Depression Scale (SDS) was used. The scale consists of 20 items. Each dimension is scored from 1 to 4. The total score ranges from 20 to 80, with higher scores indicating severer depression symptoms.

  2. Change of resilience [Outcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the intervention]

    The Connor-Davidson Resilience Scale (CD-RISC) was used. The scale consists of 25 items. Each dimension is scored from 0 to 4. The total score ranges from 0 to 100, with higher scores indicating higher resilience.

  3. Change of rumination [Outcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the intervention]

    The Ruminative Responses Scale (RRS) was used. The scale consists of 22 items. Each dimension is scored from 1 to 4. The total score ranges from 22 to 88, with higher scores indicating higher rumination

  4. Change of perceived social support [Outcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the intervention]

    The Multidimensional Scale of Perceived Social Support (MSPSS) was used. The scale consists of 12 items. Each dimension is scored from 1 to 7. The total score ranges from 12 to 84, with higher scores indicating higher perceived social support.

  5. Change of mindfulness [Outcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the intervention]

    The Short Inventory of Mindfulness Capability (SIM-C) was used. The scale consists of 12 items. Each dimension is scored from 1 to 5. The total score ranges from 12 to 60, with higher scores indicating higher mindfulness.

Other Outcome Measures

  1. Change of medication adherence [Outcomes were evaluated at baseline, immediately after the intervention, and 3 months follow-up after the intervention]

    0 (0%)~10 (100%) grade was adopted for scoring. Evaluate the condition of patients taking antiretroviral drugs according to doctor's orders in the past month

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged 18 years or older

  • been diagnosed with HIV for more than 1 month

  • screened positive with PTSD CheckList - Civilian Version (PCL-C)

  • voluntary participation

Exclusion Criteria:
  • impaired Verbal Communication

  • have received psychological treatment or related psychological intervention in the past three months

Contacts and Locations

Locations

Site City State Country Postal Code
1 The First Hospital of Changsha Changsha Hunan China 0731

Sponsors and Collaborators

  • Central South University

Investigators

  • Principal Investigator: Chulei TANG, Doctor, Central South University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TANG Chulei, Principal investigator, Central South University
ClinicalTrials.gov Identifier:
NCT05588596
Other Study ID Numbers:
  • 2018040
First Posted:
Oct 20, 2022
Last Update Posted:
Oct 20, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 20, 2022